Publications by the researcher in collaboration with JULIO EDUARDO NUÑEZ VILLOTA (104)

2024

  1. Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity

    Obesity Research and Clinical Practice, Vol. 18, Núm. 3, pp. 226-231

  2. Baseline resting heart rate and responsiveness to a home-based inspiratory muscle training program in long COVID

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 344-347

  3. CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction

    Clinical Kidney Journal, Vol. 17, Núm. 8

  4. Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study

    European Journal of Heart Failure, Vol. 26, Núm. 8, pp. 1687-1698

  5. Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: Training-HR study protocol

    Current Problems in Cardiology, Vol. 49, Núm. 12

  6. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176

  7. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

  8. Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters

    European Journal of Heart Failure

  9. Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction

    Scandinavian Cardiovascular Journal, Vol. 58, Núm. 1

  10. Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 206-214

  11. Reply to the letter regarding the article ‘Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters’

    European Journal of Heart Failure

  12. Unraveling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID

    American Journal of Medicine

  13. β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction

    JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396

2023

  1. Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 511-518

  2. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

    Scientific Reports, Vol. 13, Núm. 1

  3. Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792

  4. Maximal functional capacity in subjects with isolated left bundle branch block: A pilot study

    Clinical Cardiology, Vol. 46, Núm. 4, pp. 386-389

  5. Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 264-273

  6. Role of plasma carbohydrate antigen 125 to identify nonfrail patients in HF

    REC: CardioClinics, Vol. 58, Núm. 3, pp. 172-179

  7. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

    JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622